Αποτελέσματα Αναζήτησης
2 Αυγ 2019 · Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characteristics from non–small-cell lung cancer. SCLC has high metastatic potential, resulting in a clinically poor prognosis.
- Non–Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer deaths in...
- Non–Small Cell Lung Cancer
2 ημέρες πριν · Some people with lung cancer choose not to have treatment. For instance, you may feel that the side effects of treatment will outweigh the potential benefits. When that's the case, your healthcare professional may suggest comfort care to treat only the symptoms the cancer is causing. Surgery
Diffuse involvement with cystic or cavitary lesions may be seen in pulmonary lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, honeycomb lung associated with advanced fibrosis, diffuse bronchiectasis, and, rarely, metastatic disease.
5 Μαρ 2018 · A chronic process (≥ 12 weeks) suggests mycobacterial, fungal, viral, or parasitic infections; malignancy (primary lung cancer or metastases); or autoimmune disorders (rheumatoid arthritis and granulomatosis with polyangiitis).
Diffuse involvement with cystic or cavitary lesions may be seen in pulmonary lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, honeycomb lung associated with advanced fibrosis, diffuse bronchiectasis, and, rarely, metastatic disease.
9 Φεβ 2018 · PD-1/PD-L1 targeted immunotherapy is generally well-tolerated and has fewer acute side effects compared with standard cytotoxic chemotherapies. However, these new therapeutic agents have been linked to a growing number of immune-mediated adverse events (imAEs).
11 Οκτ 2023 · This fall 2023, my brain MRI showed a small lesion in the balance area of the brain. I had a Gamma Knife procedure (look it up, Mayo has a great explanation) to kill the DNA of that lesion. It shall go forth no more. I am now considered stage 4, but am still being treated like 3b.
